Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Procedures Review (SPR), National Institute for Occupational Safety and Health (NIOSH), 45852-45853 [2017-21046]
Download as PDF
<![CDATA[
45852
Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–0118; Docket 2017–
0001; Sequence 2]
A. Purpose
GSA is requesting that OMB review
and approve information collection,
3090–0118, Statement of Witness, SF
94. This form is used by all Federal
agencies to report accident information
involving U.S. Government motor
vehicles.
Information Collection; Statement of
Witness, Standard Form 94
Federal Vehicle Policy
Division, General Services
Administration (GSA).
ACTION: Notice of a request for
comments regarding a reinstatement,
with change, to an OMB clearance.
AGENCY:
Under the provisions of the
Paperwork Reduction Act of 1995, GSA
has submitted to the Office of
Management and Budget (OMB) a
request to review and approve a
reinstatement, with change, to an
information collection requirement
concerning Standard Form 94,
Statement of Witness.
DATES: Submit comments on or before
December 1, 2017.
FOR FURTHER INFORMATION CONTACT: Ray
Wynter, Federal Vehicle Policy
Division, 202–501–3802, or via email at
ray.wynter@gsa.gov.
ADDRESSES: Submit comments
identified by Information Collection
3090–0118, Statement of Witness, SF
94, by any of the following methods:
Regulations.gov: https://
www.regulations.gov.
• Regulations.gov: https://
www.regulations.gov. Submit comments
via the Federal eRulemaking portal by
searching the OMB control number.
Select the link ‘‘Submit a Comment’’
that corresponds with ‘‘Information
Collection 3090–0118, Statement of
Witness, SF 94.’’ Follow the instructions
provided at the ‘‘Submit a Comment’’
screen. Please include your name,
company name (if any), and
‘‘Information Collection 3090–0118,
Statement of Witness, SF 94’’ on your
attached document.
• Mail: General Services
Administration, Regulatory Secretariat
Division (MVCB), 1800 F Street NW.,
Washington, DC 20405. ATTN: Mr. Poe/
IC 3090–0118, Statement of Witness, SF
94.
Instructions: Please submit comments
only and cite Information Collection
3090–0118, Statement of Witness, SF
94, in all correspondence related to this
collection. Comments received generally
will be posted without change to https://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two to three days after
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:01 Sep 29, 2017
Jkt 244001
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
SUPPLEMENTARY INFORMATION:
B. Annual Reporting Burden
Respondents: 874.
Responses per Respondent: 1.
Total Annual Responses: 874.
Hours per Response: .333.
Total Burden Hours: 291.
C. Public Comment
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 3090–0118,
Statement of Witness, SF 94, in all
correspondence.
Dated: September 26, 2017.
David A. Shive,
Chief Information Officer, General Services
Administration.
[FR Doc. 2017–20983 Filed 9–29–17; 8:45 am]
BILLING CODE 6820–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), Subcommittee on
Procedures Review (SPR), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with section
10(a)(2) of the Federal Advisory
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting for the Subcommittee
on Procedures Review (SPR) of the
Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number at 1–866–659–0537; the pass
code is 9933701. The conference line
has 150 ports for callers.
DATES: The meeting will be held on
November 20, 2017, 11:00 a.m. to 4:30
p.m. ET.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30333, Telephone (513) 533–
6800, Toll Free 1(800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on March 22, 2016,
E:\FR\FM\02OCN1.SGM
02OCN1
Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. SPR
was established to aid the Advisory
Board in carrying out its duty to advise
the Secretary, HHS, on dose
reconstruction. SPR is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor (Oak
Ridge Associated Universities—ORAU).
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction
procedures: DCAS Program Evaluation
Report 59 (addressing dose
reconstructions at the Norton Company,
Worcester MA); DCAS Report 5:
Alternative Dissolution Models for
Insoluble Plutonium 238; Outstanding
Findings of Prior Subcommittee
Reviews; and DCAS Procedures Not Yet
Reviewed. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–21046 Filed 9–29–17; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
19:01 Sep 29, 2017
Jkt 244001
45853
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Food and Drug Administration
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–D–5140 for ‘‘Display Devices for
Diagnostic Radiology’’ comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
[Docket No. FDA–2017–D–5140]
Display Devices for Diagnostic
Radiology; Guidance for Industry and
Food and Drug Administration Staff;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of the
guidance entitled ‘‘Display Devices for
Diagnostic Radiology.’’ This guidance
document provides recommendations
for the types of information you should
provide in your premarket notification
submission (510(k)) for display devices
intended for diagnostic radiology with
the assigned product code PGY. This
guidance replaces a previously issued
final guidance entitled ‘‘Display
Accessories for Full-Field Digital
Mammography Systems-Premarket
Notification (510(k)) Submissions’’
issued on May 30, 2008.
DATES: The announcement of the
guidance is published in the Federal
Register on October 2, 2017.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Pages 45852-45853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21046]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), Subcommittee on Procedures Review (SPR), National
Institute for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the Subcommittee
on Procedures Review (SPR) of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
a public comment period. The public is welcome to submit written
comments in advance of the meeting, to the contact person below.
Written comments received in advance of the meeting will be included in
the official record of the meeting. The public is also welcome to
listen to the meeting by joining the teleconference at the USA toll-
free, dial-in number at 1-866-659-0537; the pass code is 9933701. The
conference line has 150 ports for callers.
DATES: The meeting will be held on November 20, 2017, 11:00 a.m. to
4:30 p.m. ET.
ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537; the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia
30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, Email
ocas@cdc.gov.
SUPPLEMENTARY INFORMATION: Background: The Advisory Board was
established under the Energy Employees Occupational Illness
Compensation Program Act of 2000 to advise the President on a variety
of policy and technical functions required to implement and effectively
manage the new compensation program. Key functions of the Advisory
Board include providing advice on the development of probability of
causation guidelines that have been promulgated by the Department of
Health and Human Services (HHS) as a final rule; advice on methods of
dose reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose estimation
and reconstruction efforts being performed for purposes of the
compensation program; and advice on petitions to add classes of workers
to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016,
[[Page 45853]]
pursuant to Executive Order 13708, and will expire on September 30,
2017.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SPR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction. SPR is responsible
for overseeing, tracking, and participating in the reviews of all
procedures used in the dose reconstruction process by the NIOSH
Division of Compensation Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge Associated Universities--ORAU).
Matters to be Considered: The agenda will include discussions on
the following dose reconstruction procedures: DCAS Program Evaluation
Report 59 (addressing dose reconstructions at the Norton Company,
Worcester MA); DCAS Report 5: Alternative Dissolution Models for
Insoluble Plutonium 238; Outstanding Findings of Prior Subcommittee
Reviews; and DCAS Procedures Not Yet Reviewed. Agenda items are subject
to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-21046 Filed 9-29-17; 8:45 am]
BILLING CODE 4163-19-P
